United States News Todas as matérias

Kaspi.kz (NASDAQ:KSPI) announced it completed the acquisition of Rabobank A.Ş. to expand its digital banking operations for its regional network of 25 million consumers.

Conagra Brands (NYSE:CAG) reported Q4 fiscal 2026 net sales of $2.9 billion, a diluted loss of $3.37 per share and an annualized dividend cut to $0.70.

Morgan Stanley (NYSE:MS) reported record Q2 2026 net revenue of $21.3 billion and diluted EPS of $3.46 as its major business divisions expanded.

Bruker (NASDAQ:BRKR) acquired DISQVER, an mNGS platform that can analyze blood-derived cell-free DNA for more than 11,000 microbes within 24 hours.

Axsome Therapeutics (NASDAQ:AXSM) announced the FDA accepted its New Drug Application for narcolepsy treatment AXS-12, setting a 2027 target date.

Veradermics (NYSE:MANE) reported that its VDPHL01 treatment produced an average increase of up to 23.3 hairs per square centimeter in female patients over six months.

Highway Holdings (NASDAQ:HIHO) reported fiscal 2026 revenue of $4.8 million and a shareholder-attributable net loss of $1.5 million, or $0.33 per share.

Pediatrix Medical Group (NYSE:MD) said its second-quarter payor mix remained stable and reaffirmed its $280–$300 million 2026 Adjusted EBITDA outlook.

BNY (NYSE:BNY) reported second-quarter revenue of $5.7 billion alongside an adjusted earnings per share of $2.45.

VCI Global (NASDAQ:VCIG) reported fiscal 2025 revenue of $26.1 million, down 6.2%, and a net loss attributable to shareholders of $30.3 million.

PNC (NYSE:PNC) reported a second-quarter net income of $2.1 billion and a record total revenue of $6.9 billion.

Johnson & Johnson (NYSE:JNJ) reported second-quarter sales of $25.3 billion alongside a reported earnings per share of $2.27.

Fractyl Health (NASDAQ:GUTS) reported one-year REMAIN-1 data showing 7.8% weight regain with Revita versus 13% with sham in 45 participants.

BlackRock (NYSE:BLK) reported second-quarter revenue of $7.08 billion as total assets surpassed $15 trillion for the first time.

Elevance Health (NYSE:ELV) reported second-quarter 2026 operating revenue of $49.8 billion and a diluted earnings per share of $6.71.

M&T Bank (NYSE:MTB) reported second-quarter 2026 net income of $818 million and a diluted earnings per share of $5.32.

Kandi Technologies (NASDAQ:KNDI) began production at its Lin’an manufacturing base, which the company expects could produce up to 200 battery-swap stations annually.

Brent crude futures rose 0.7% to $85.31 a barrel, while West Texas Intermediate futures gained 0.4% to $79.69 as U.S.-Iran hostilities intensified.

ARC Resources shareholders approved its approximately C$22 billion acquisition by Shell (NYSE:SHEL), with 99.54% backing the arrangement.

ASML (NASDAQ:ASML) reported Q2 2026 net sales of €9.3 billion and raised full-year guidance to €43–€45 billion, which the company linked to stronger AI-related chip demand.

Plumas Bancorp (NASDAQ:PLBC) reported record Q2 2026 net income of $9.9 million, or $1.43 per basic share.

Merck (NYSE:MRK) said its 299-patient KEYNOTE-C93 trial met its PFS endpoint for Keytruda monotherapy versus chemotherapy in dMMR endometrial cancer.

Cameco (NYSE:CCJ) resumed production at Cigar Lake and maintained its 2026 output forecast of 17.5–18 million pounds of U3O8.

Aehr Test Systems (NASDAQ:AEHR) reported fourth-quarter revenue of $18.8 million and a record $60.7 million in bookings.